DUNN JOHN MICHAEL 4
4 · Acer Therapeutics Inc. · Filed Sep 21, 2017
Insider Transaction Report
Form 4
DUNN JOHN MICHAEL
Director
Transactions
- Other
Nonqualified Stock Option (right to buy)
2017-09-19+16,000→ 16,000 totalExercise: $2.55Exp: 2025-10-19→ Common Stock (16,000 underlying) - Other
Common Stock
2017-09-19+5,952→ 5,952 total
Footnotes (3)
- [F1]Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for 5,952 shares of common stock of Private Acer.
- [F2]Received in connection with the Merger in exchange for an option to acquire 16,000 shares of common stock of Private Acer.
- [F3]Option vests in eight equal quarterly installments beginning on October 19, 2015.